Total Payments
$185,699
2024 Payments
$30,902
Companies
11
Transactions
157
Medicare Patients
95
Medicare Billing
$3,461
Payment Breakdown by Category
Consulting$117,875 (63.5%)
Other$36,493 (19.7%)
Travel$28,701 (15.5%)
Food & Beverage$2,531 (1.4%)
Education$99.95 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $117,875 | 11 | 63.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $36,493 | 53 | 19.7% |
| Travel and Lodging | $28,701 | 37 | 15.5% |
| Food and Beverage | $2,531 | 55 | 1.4% |
| Education | $99.95 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $137,465 | 37 | $0 (2024) |
| Gilead Sciences, Inc. | $47,114 | 103 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $370.74 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $191.89 | 4 | $0 (2024) |
| Amgen Inc. | $147.74 | 3 | $0 (2022) |
| Novocure Inc. | $130.29 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $124.96 | 1 | $0 (2024) |
| SpringWorks Therapeutics, Inc. | $78.99 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $34.92 | 2 | $0 (2022) |
| Seagen Inc. | $24.58 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30,902 | 14 | Novartis Pharmaceuticals Corporation ($30,320) |
| 2023 | $107,328 | 26 | NOVARTIS PHARMACEUTICALS CORPORATION ($107,088) |
| 2022 | $32,132 | 73 | Gilead Sciences, Inc. ($31,789) |
| 2021 | $15,337 | 44 | Gilead Sciences, Inc. ($15,202) |
All Payment Transactions
157 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $127.73 | General |
| 09/18/2024 | SpringWorks Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $78.99 | General |
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $125.25 | General |
| Category: Oncology | ||||||
| 05/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 04/17/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: Oncology | ||||||
| 03/08/2024 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), SANDOSTATIN, KISQALI | Consulting Fee | Cash or cash equivalent | $2,875.00 | General |
| Category: Oncology | ||||||
| 03/08/2024 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), SANDOSTATIN, KISQALI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $212.89 | General |
| Category: Oncology | ||||||
| 03/08/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), SANDOSTATIN, PIQRAY | Travel and Lodging | In-kind items and services | $77.87 | General |
| Category: Oncology | ||||||
| 02/29/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), SANDOSTATIN, PIQRAY | Consulting Fee | Cash or cash equivalent | $11,500.00 | General |
| Category: Oncology | ||||||
| 02/29/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY, SANDOSTATIN | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $825.00 | General |
| Category: Oncology | ||||||
| 02/29/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), SANDOSTATIN, PIQRAY | Travel and Lodging | In-kind items and services | $492.09 | General |
| Category: Oncology | ||||||
| 01/31/2024 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), SANDOSTATIN, KISQALI | Consulting Fee | Cash or cash equivalent | $11,500.00 | General |
| Category: Oncology | ||||||
| 01/31/2024 | Novartis Pharmaceuticals Corporation | SANDOSTATIN (Drug), KISQALI, PIQRAY | Travel and Lodging | In-kind items and services | $2,011.86 | General |
| Category: Oncology | ||||||
| 01/31/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY, SANDOSTATIN | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $825.00 | General |
| Category: Oncology | ||||||
| 12/31/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | PIQRAY (Drug), SANDOSTATIN, KISQALI | Consulting Fee | Cash or cash equivalent | $11,500.00 | General |
| Category: Oncology | ||||||
| 12/31/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | SANDOSTATIN (Drug) | Consulting Fee | Cash or cash equivalent | $11,500.00 | General |
| Category: Oncology | ||||||
| 12/31/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | SANDOSTATIN (Drug) | Consulting Fee | Cash or cash equivalent | $11,500.00 | General |
| Category: Oncology | ||||||
| 12/31/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | SANDOSTATIN (Drug) | Consulting Fee | Cash or cash equivalent | $11,500.00 | General |
| Category: Oncology | ||||||
| 12/31/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | SANDOSTATIN (Drug) | Consulting Fee | Cash or cash equivalent | $11,500.00 | General |
| Category: Oncology | ||||||
| 12/31/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | SANDOSTATIN (Drug) | Travel and Lodging | In-kind items and services | $1,698.41 | General |
| Category: Oncology | ||||||
| 12/31/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | SANDOSTATIN (Drug) | Travel and Lodging | In-kind items and services | $1,043.27 | General |
| Category: Oncology | ||||||
| 12/31/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | SANDOSTATIN (Drug) | Travel and Lodging | In-kind items and services | $900.00 | General |
| Category: Oncology | ||||||
| 12/31/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | SANDOSTATIN (Drug) | Travel and Lodging | In-kind items and services | $852.10 | General |
| Category: Oncology | ||||||
| 12/31/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | PIQRAY (Drug), KISQALI, SANDOSTATIN | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $825.00 | General |
| Category: Oncology | ||||||
| 12/31/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | SANDOSTATIN (Drug) | Travel and Lodging | In-kind items and services | $825.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 18 | 21 | $2,625 | $562.95 |
| 2021 | 1 | 44 | 70 | $8,550 | $2,006 |
| 2020 | 1 | 33 | 45 | $4,500 | $892.34 |
Total Patients
95
Total Services
136
Medicare Billing
$3,461
Procedure Codes
3
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 18 | 21 | $2,625 | $562.95 | 21.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 44 | 70 | $8,550 | $2,006 | 23.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 33 | 45 | $4,500 | $892.34 | 19.8% |
About Kara Trlica, APRN
Kara Trlica, APRN is a Family healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992816813.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kara Trlica, APRN has received a total of $185,699 in payments from pharmaceutical and medical device companies, with $30,902 received in 2024. These payments were reported across 157 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($117,875).
As a Medicare-enrolled provider, Trlica has provided services to 95 Medicare beneficiaries, totaling 136 services with total Medicare billing of $3,461. Data is available for 3 years (2020–2022), covering 3 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location New York, NY
- Active Since 08/31/2006
- Last Updated 08/04/2014
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1992816813
Products in Payments
- SANDOSTATIN (Drug) $57,577
- Trodelvy (Drug) $47,114
- PIQRAY (Drug) $41,940
- KISQALI (Drug) $37,948
- KEYTRUDA (Biological) $191.89
- Optune (Device) $130.29
- CALQUENCE (Drug) $125.25
- DARZALEX (Biological) $124.96
- TAGRISSO (Drug) $117.76
- Nplate (Biological) $47.79
- TUKYSA (Drug) $24.58
- ENHERTU (Drug) $17.64
- Enhertu (Drug) $17.28
- Flexitouch Plus (Device) $16.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in New York
Casey Grillo
Family — Payments: $152,351
Family $152,351
Mary Sullivan-Whalen, Fnp, FNP
Family — Payments: $113,037
Family $113,037
Christina Nalbone, Msn, Fnp-C, MSN, FNP-C
Family — Payments: $102,530
Family $102,530
Derek Pineda, Np, NP
Family — Payments: $32,887
Family $32,887
Miss. Leslie Worona, Fnp-Bc, FNP-BC
Family — Payments: $24,032
Family $24,032
Tara Mccabe, N.p, N.P
Family — Payments: $20,890
Family $20,890